...
首页> 外文期刊>Advances in Radiation Oncology >Increase in Superficial Dose in Whole-Breast Irradiation With Halcyon Straight-Through Linac Compared With Traditional C-arm Linac With Flattening Filter: In?vivo Dosimetry and Planning Study
【24h】

Increase in Superficial Dose in Whole-Breast Irradiation With Halcyon Straight-Through Linac Compared With Traditional C-arm Linac With Flattening Filter: In?vivo Dosimetry and Planning Study

机译:与传统的平展过滤器C型臂直线加速器相比,Halcyon直通直线加速器对全乳照射的表观剂量增加:体内剂量和计划研究

获取原文
           

摘要

PurposeSuperficial dose is an important parameter in breast cancer radiation therapy. When treated with conventional linacs, bolus is commonly applied to improve target coverage near the surface while also managing the risk of severe skin reactions and negative cosmesis. With the introduction of modern linacs with 6X flattening filter free (FFF) photon beams, the effect on superficial dose and the need for bolus must be evaluated.Methods and MaterialsIn?vivo measurements of superficial dose were made with optically stimulated luminescence dosimeters on 11 breast cancer patients treated with the Halcyon 6X FFF linac (Varian Medical Systems, Palo Alto, CA). Additionally, measurements were made with the Halycon 6X FFF beam and a 6X beam with flattening filter (FF) delivered to an anthropomorphic phantom. A planning study was carried out in which 14 patients treated on the Halcyon were replanned with a conventional linac to determine the difference in superficial dose predicted by the treatment planning system. Measures were taken to increase the accuracy of the treatment planning system superficial dose.ResultsThe use of the Halcyon 6X FFF beam led to higher superficial dose compared with 6X FF beams. The in?vivo measurements show an average superficial dose of 83.8%?±?0.6%, which is an increase of approximately 10% compared with published measurements for a 6X FF linac. Comparison of superficial dose for 6X FF and 6X FFF beams in the phantom measurements show an increase from 70%?±?1.3% to 84%?±?1.3%, which is consistent with the in?vivo measurements. The planning comparison shows an increase in V70%Rx from 62%?±?4.4% to 81%?±?2.2% for the?superficial breast tissue for the Halcyon 6X FFF beam compared with a standard C-arm linac with FF.ConclusionsThe use of the Halcyon 6X FFF beam was associated with higher superficial dose which may obviate the use of bolus.
机译:目的表面剂量是乳腺癌放射治疗中的重要参数。当使用传统的直线加速器治疗时,通常会使用推注来改善表面附近的目标覆盖范围,同时还应对严重的皮肤反应和美容不良的风险。随着引入具有6倍扁平化无滤光片(FFF)光子束的直线加速器,必须评估其对浅表剂量的影响和推注的需要。方法和材料采用光学激发发光剂量计对11个乳房进行体内表观剂量的体内测量。用Halcyon 6X FFF直线加速器(加利福尼亚州帕洛阿尔托的Varian Medical Systems)治疗的癌症患者。此外,还使用Halycon 6X FFF光束和带有平坦滤光片(FF)的6X光束进行了测量,该光束被传送到拟人模型。进行了一项计划研究,其中用常规直线加速器对在Halcyon上治疗的14位患者进行了重新计划,以确定治疗计划系统预测的浅表剂量差异。结果采取了措施以提高治疗计划系统表面剂量的准确性。结果与6X FF光束相比,Halcyon 6X FFF光束的使用导致较高的表面剂量。体内测量显示平均表面剂量为83.8%±±0.6%,与6X FF直线加速器的公开测量相比增加了约10%。在幻像测量中比较6X FF和6X FFF光束的表面剂量,显示从70%±1.3%增至84%±1.3%,这与体内测量结果一致。计划比较显示,与标准C臂直线加速器和FF相比,Halcyon 6X FFF束的浅表乳腺组织的V70%Rx从62%±4.4%增至81%±2.2%。使用Halcyon 6X FFF光束与较高的表面剂量有关,可能会避免使用推注。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号